Abbott Laboratories vs. Mirum Pharmaceuticals, Inc. Common Stock
ABT
Abbott Laboratories
$102.83 +0.58%
VS MIRMMirum Pharmaceuticals, Inc. Common Stock
$98.22 -2.38%
Abbott Laboratories (ABT) comes out ahead, leading on 5 of 8 compared factors.
Size & Scale
| ABT | MIRM | |
|---|---|---|
| Market Cap | $176.90 billion | $6.53 billion |
| Revenue (TTM) | $46.59 billion | $618.07 million |
| Net Income (TTM) | $5.42 billion | $-860,207,000 |
ABT leads on 3 of 3 size & scale factors.
Valuation
| ABT | MIRM | |
|---|---|---|
| P/E Ratio | 33.28 | — |
| Price / Book | 3.42 | -626.83 |
| Price / Sales | 3.80 | 10.57 |
ABT and MIRM split the valuation factors evenly.
Profitability
| ABT | MIRM | |
|---|---|---|
| Net Margin | 11.65% | -139.18% |
| Return on Equity | 10.48% | 8253.76% |
ABT and MIRM split the profitability factors evenly.
Dividend
| ABT | MIRM | |
|---|---|---|
| Dividend Yield | 2.45% | — |
| Payout Ratio | 81.55 | — |
ABT and MIRM split the dividend factors evenly.
Risk & Sentiment
| ABT | MIRM | |
|---|---|---|
| Short Interest | 0.57% | 0.09% |
MIRM leads on 1 of 1 risk & sentiment factors.
Dig deeper: ABT overview, ABT financials, MIRM overview, MIRM financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.